News + Filings Transactions
|
Viswanathan Ravi
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/10/2018 | Elastic N.V. | ESTC | Conversion | Series C Convertible Preference Shares | 4.2M | $0.00 | $0 | See Note 2 | 10/10/2018 |
| 10/10/2018 | Elastic N.V. | ESTC | Conversion | Ordinary Shares | 1.5M | $0.00 | $0 | See Note 3 | 10/10/2018 |
| 10/10/2018 | Elastic N.V. | ESTC | Conversion | Ordinary Shares | 4.2M | $0.00 | $0 | See Note 2 | 10/10/2018 |
| 10/10/2018 | Elastic N.V. | ESTC | Conversion | Series D Convertible Preference Shares | 1.5M | $0.00 | $0 | See Note 3 | 10/10/2018 |
| 09/07/2018 | Adaptimmune Therapeutics PLC | ADAP | Purchase | | 12M | $1.67 | $20M | See Note 5 | 09/07/2018 |
| 09/07/2018 | Adaptimmune Therapeutics PLC | ADAP | Purchase | | 3M | $1.67 | $5M | See Note 3 | 09/07/2018 |
| 08/21/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 663.7k | $2.26 | $1.5M | See Note 1 | 08/21/2018 |
| 07/19/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 50.6k | $2.00 | $101.2k | See Note 2 | 07/18/2018 |
| 07/18/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 200k | $1.95 | $390.6k | See Note 2 | 07/18/2018 |
| 06/28/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 187.1k | $2.10 | $392.7k | See Note 1 | 06/27/2018 |
| 06/27/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 5.3k | $2.15 | $11.4k | See Note 1 | 06/27/2018 |
| 05/30/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 275 | $2.15 | $591.2 | See Note 1 | 05/30/2018 |
| 05/25/2018 | ARDELYX, INC. | ARDX | Grant | Common Stock | 416.7k | $4.00 | $1.7M | See Note 1 | 05/25/2018 |
| 05/25/2018 | ARDELYX, INC. | ARDX | Grant | Common Stock | 416.7k | $4.00 | $1.7M | See Note 2 | 05/25/2018 |
| 05/21/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 32.2k | $2.14 | $69.1k | See Note 2 | 05/17/2018 |
| 05/18/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 20.1k | $2.14 | $42.9k | See Note 2 | 05/17/2018 |
| 05/17/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 184.2k | $2.13 | $391.4k | See Note 2 | 05/17/2018 |
| 05/08/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 70.9k | $2.13 | $151.3k | See Note 2 | 05/08/2018 |
| 05/01/2018 | MULESOFT, INC | MULE | Conversion | Class B Common Stock | 859k | $0.00 | $0 | See Note 5 | 05/01/2018 |
| 05/01/2018 | MULESOFT, INC | MULE | Conversion | Class B Common Stock | 2.6M | $0.00 | $0 | See Note 4 | 05/01/2018 |
| 05/01/2018 | MULESOFT, INC | MULE | Conversion | Class B Common Stock | 12.7M | $0.00 | $0 | See Note 2 | 05/01/2018 |
| 05/01/2018 | MULESOFT, INC | MULE | Other | Class A Common Stock | 859k | $0.00 | $0 | See Note 5 | 05/01/2018 |
| 05/01/2018 | MULESOFT, INC | MULE | Conversion | Class A Common Stock | 859k | $0.00 | $0 | See Note 5 | 05/01/2018 |
| 05/01/2018 | MULESOFT, INC | MULE | Other | Class A Common Stock | 2.6M | $0.00 | $0 | See Note 4 | 05/01/2018 |
| 05/01/2018 | MULESOFT, INC | MULE | Conversion | Class A Common Stock | 2.6M | $0.00 | $0 | See Note 4 | 05/01/2018 |
| 05/01/2018 | MULESOFT, INC | MULE | Other | Class A Common Stock | 12.7M | $0.00 | $0 | See Note 2 | 05/01/2018 |
| 05/01/2018 | MULESOFT, INC | MULE | Conversion | Class A Common Stock | 12.7M | $0.00 | $0 | See Note 2 | 05/01/2018 |
| 04/23/2018 | Surface Oncology, Inc. | SURF | Conversion | Common Stock | 3.2M | $0.00 | $0 | See Note 2 | 04/23/2018 |
| 04/23/2018 | Surface Oncology, Inc. | SURF | Purchase | Common Stock | 133.3k | $15.00 | $2M | See Note 2 | 04/23/2018 |
| 04/23/2018 | Surface Oncology, Inc. | SURF | Conversion | Series A Preferred Stock | 7M | $0.00 | $0 | See Note 2 | 04/23/2018 |
| 04/10/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 203.2k | $2.46 | $500k | See Note 2 | 04/06/2018 |
| 04/09/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 32.1k | $2.43 | $78.1k | See Note 2 | 04/06/2018 |
| 04/06/2018 | AVEO PHARMACEUTICALS, INC. | AVEO | Purchase | Common Stock | 685.7k | $2.24 | $1.5M | See Note 2 | 04/06/2018 |
| 03/27/2018 | Adaptimmune Therapeutics PLC | ADAP | Purchase | | 6M | $1.92 | $11.5M | See Note 3 | 03/26/2018 |
| 03/27/2018 | Tracon Pharmaceuticals, Inc. | TCON | Purchase | Common Stock | 708k | $2.70 | $1.9M | See Note 2 | 03/27/2018 |
|
|